Study of Multi-mode Thermal Therapy Combined With Immunotherapy In Patients With HER2-negative Breast Cancer With Liver Metastases: A Prospective, Open-label, Phase II Trial
Latest Information Update: 17 Mar 2026
At a glance
- Drugs Adebrelimab (Primary) ; Pembrolizumab (Primary) ; Sacituzumab Tirumotecan (Primary) ; Trastuzumab rezetecan (Primary)
- Indications Advanced breast cancer; HER2 negative breast cancer; Liver metastases
- Focus Therapeutic Use
Most Recent Events
- 17 Mar 2026 New trial record